Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Rein
- | Specialty :
- Thérapies Ciblées
Extract
A Randomized Trial of Temsirolimus Versus Sorafenib as Second-Line Therapy in Patients With Advanced Renal Cell Carcinoma Who Have Failed First-Line Sunitinib Therapy.
Scientific Abstract
en cours d'intégration;